搜索临床试验以:手机应用测试
总计550个结果
-
Hospital Universitario Mayor MederiUniversidad del Rosario尚未招聘抗生素抗性菌株 | 胆道感染
-
University Hospital Inselspital, Berne完全的
-
University of California, Los AngelesNational Institute on Drug Abuse (NIDA); Medical University of South Carolina; University of Arkansas招聘中
-
H. Lee Moffitt Cancer Center and Research InstitutePfizer主动,不招人
-
M.D. Anderson Cancer CenterInflammatory Breast Cancer Network Foundation终止
-
Hospital Sant Joan de DeuOfficial Barcelona Nurses Association (COIB)完全的
-
Central Hospital, Nancy, FranceMinistry of Health, France完全的
-
Dow University of Health SciencesUniversity of Karachi招聘中
-
Oslo University HospitalVestre Viken Hospital Trust; University of Oslo; Göteborg University; University Hospital of North... 和其他合作者招聘中
-
University of VirginiaMedical University of South Carolina; National Institute of Neurological Disorders and Stroke... 和其他合作者完全的
-
Universidad Peruana Cayetano HerediaNational Institutes of Health (NIH); NGO Via Libre完全的
-
Maimonides Medical CenterAmerican Urological Association招聘中
-
Vanderbilt University Medical Center招聘中
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI)完全的
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaUniversity of Bologna尚未招聘
-
I.M. Sechenov First Moscow State Medical University完全的
-
University of British ColumbiaEli Lilly and Company; Canadian Institutes of Health Research (CIHR); Janssen-Ortho Inc., Canada完全的
-
Massachusetts General HospitalGenentech, Inc.完全的
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)完全的卵巢子宫内膜样腺癌 | 卵巢浆液性癌 | 卵巢未分化癌 | 输卵管癌 | 卵巢透明细胞腺癌 | 卵巢粘液腺癌 | 输卵管移行细胞癌 | 卵巢移行细胞癌 | 输卵管透明细胞腺癌 | 输卵管子宫内膜样腺癌 | 输卵管粘液腺癌 | 输卵管浆液性腺癌 | 输卵管未分化癌 | 恶性卵巢布伦纳瘤 | 卵巢浆液性腺癌 | 原发性腹膜浆液性腺癌 | 原发性腹膜癌 | FIGO III 期卵巢癌 | FIGO IIIA 期卵巢癌 | FIGO IIIA1 期卵巢癌 | FIGO IIIA2期卵巢癌 | FIGO IIIB 期卵巢癌 | FIGO IIIC 期卵巢癌 | FIGO IVA 期卵巢癌 | FIGO IVB 期卵巢癌 | FIGO IIIA1(i) 期卵巢癌 | FIGO IIIA1(ii) 期卵巢癌美国
-
Kirby InstituteNational Heart, Lung, and Blood Institute (NHLBI); St Vincent's Hospital, Sydney完全的
-
West Virginia University邀请报名